Literature DB >> 2419685

Effects of amiodarone and its metabolite, desethylamiodarone, on the electrophysiologic properties of isolated cardiac muscle.

S M Yabek, R Kato, B N Singh.   

Abstract

The electrophysiologic (EP) effects of chronically administered amiodarone (AM) is known, but the nature of its acute effects are unclear. Whether the delayed onset of AM action is due to its metabolite, desethylamiodarone (DAM), is also uncertain. By standard microelectrode techniques in isolated canine ventricular muscle (VM) and Purkinje fibers (PF) and in rabbit sinoatrial (SA) node and atrium, we therefore studied the comparative effects of AM and DAM, 10(-6) M (0.68 micrograms/ml), 10(-5) M (6.8 micrograms/ml), and 5 X 10(-5) M (34 micrograms/ml), dissolved in ethanol and homologous serum. In VM, PF, and atria stimulated at 1 Hz, AM and DAM had no effect on Vmax, action potential amplitude (APA), or resting membrane potential. At 2-4 Hz, AM exerted a marked use-dependent effect in VM and PF. In atria, 5 X 10(-5) M, AM and DAM increased (p less than 0.01) action potential duration at 90% repolarization (APD90); the effective refractory period (ERP) increased by 10.5% (p less than 0.05 for AM) and 21.6% (p less than 0.01 for DAM). In VM, AM increased APD90 by 9.6% (p less than 0.01) at 10(-6) M, 13.7% (p less than 0.01) at 10(-5) M, and 16.9% (p less than 0.01) at 5 X 10(-5) M. The corresponding values for DAM were 5.6% (NS), and 7.3% (p less than 0.01), respectively. The ERP in VM was increased significantly by AM but not by DAM at all 3 drug concentrations without a change in APD90/ERP ratio. In PF, AM and DAM decreased APD50 and APD90; the effects were greater than those produced by the superfusion medium, but the degree of shortening in ERP induced by AM and DAM was not. AM and DAM (10(-5) and 5 X 10(-5) M) increased spontaneous cycle length of rabbit SA node. AM significantly decreased slope of phase 4 depolarization (10.4% at 10(-6) M, p less than 0.05; 14.5% at 10(-5) M, p less than 0.01; 24.0% at 5 X 10(-5) M, p less than 0.01). At 5 X 10(-5) M, AM significantly decreased APA, maximum diastolic potential and threshold potential with an insignificant effect on APD100.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2419685     DOI: 10.1097/00005344-198601000-00029

Source DB:  PubMed          Journal:  J Cardiovasc Pharmacol        ISSN: 0160-2446            Impact factor:   3.105


  12 in total

1.  Efficacy and safety of intravenous amiodarone in recent-onset atrial fibrillation: experience in patients admitted to a general internal medicine department.

Authors:  Y Kreiss; Y Sidi; H Gur
Journal:  Postgrad Med J       Date:  1999-05       Impact factor: 2.401

2.  Block of cardiac sodium channels by amiodarone studied by using Vmax of action potential in single ventricular myocytes.

Authors:  H Honjo; I Kodama; K Kamiya; J Toyama
Journal:  Br J Pharmacol       Date:  1991-03       Impact factor: 8.739

Review 3.  Drug effects on the electrocardiogram. A review of their clinical importance.

Authors:  J D Symanski; L S Gettes
Journal:  Drugs       Date:  1993-08       Impact factor: 9.546

4.  Comparison of the chronic and acute effects of amiodarone on the calcium and potassium currents in rabbit isolated cardiac myocytes.

Authors:  A Varró; L Virág; J G Papp
Journal:  Br J Pharmacol       Date:  1996-03       Impact factor: 8.739

Review 5.  Recent advances in understanding the pharmacology of amiodarone.

Authors:  S Nattel; M Talajic
Journal:  Drugs       Date:  1988-08       Impact factor: 9.546

Review 6.  Pharmacokinetic drug interactions with amiodarone.

Authors:  L J Lesko
Journal:  Clin Pharmacokinet       Date:  1989-08       Impact factor: 6.447

Review 7.  Amiodarone in long term prophylaxis.

Authors:  D Katritsis; A J Camm
Journal:  Drugs       Date:  1991       Impact factor: 9.546

8.  Effects of long-term oral administration of amiodarone on the electromechanical performance of rabbit ventricular muscle.

Authors:  I Kodama; R Suzuki; K Kamiya; H Iwata; J Toyama
Journal:  Br J Pharmacol       Date:  1992-10       Impact factor: 8.739

9.  Resting, and rate-dependent depression of Vmax of guinea-pig ventricular action potentials by amiodarone and desethylamiodarone.

Authors:  R T Pallandi; T J Campbell
Journal:  Br J Pharmacol       Date:  1987-09       Impact factor: 8.739

10.  Effect of mexiletine, amiodarone and disopyramide on the excitability and refractoriness of canine cardiac fibers: possible relation to antiarrhythmic drug action and classification.

Authors:  Y Nakaya; V Elharrar; B Surawicz
Journal:  Cardiovasc Drugs Ther       Date:  1987-08       Impact factor: 3.727

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.